Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Atopic Dermatitis \(AD\)”

244 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 244 results

Post-approval studies (Phase 4)Study completedNCT00119158
What this trial is testing

Combination Therapy for Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Children's Hospital of Philadelphia 90
Not applicableLooking for participantsNCT03936335
What this trial is testing

An Observational Retrospective Cohort Study Being Conducted in Women With Atopic Dermatitis (AD)

Who this might be right for
Adverse Pregnancy OutcomesAtopic Dermatitis
Regeneron Pharmaceuticals 3,930
Not applicableActive Not RecruitingNCT03992417
What this trial is testing

Observational Study of Patients Receiving Dupixent® for Atopic Dermatitis (AD)

Who this might be right for
Dermatitis Atopic
Sanofi 955
Testing effectiveness (Phase 2)Active Not RecruitingNCT05509023
What this trial is testing

Evaluating Safety and Efficacy of ADX-914 in Patients With Moderate to Severe Atopic Dermatitis (SIGNAL-AD)

Who this might be right for
Atopic Dermatitis
Q32 Bio Inc. 102
Not applicableLooking for participantsNCT06943469
What this trial is testing

Effect of Partially Hydrolyzed Formula With Synbiotics on Skin Barrier Function

Who this might be right for
Atopic Dermatitis (AD)
Société des Produits Nestlé (SPN) 400
Not applicableLooking for participantsNCT07316465
What this trial is testing

Birth Cohort: Development of IgE Autoantibodies in Newborns With (High Risk of) Atopic Dermatitis

Who this might be right for
Atopic Dermatitis (AD)AutoantibodyAuto-Immunity+4 more
Universitair Ziekenhuis Brussel 500
Testing effectiveness (Phase 2)UnknownNCT05905133
What this trial is testing

Evaluate the Safety and Efficacy of CBP-201 in Chinese Adult Subjects With Moderate to Severe AD

Who this might be right for
Atopic Dermatitis
Connect Biopharm LLC 360
Not applicableEnded earlyNCT05639738
What this trial is testing

Assessment of Clinical, Biological and Biometrological Paramaters in Adult Subjects Suffering From AD

Who this might be right for
Dermatitis, Atopic
Pierre Fabre Dermo Cosmetique 12
Large-scale testing (Phase 3)Not Yet RecruitingNCT07767253
What this trial is testing

Evaluation of 611 in Chinese Children With Moderate to Severe Atopic Dermatitis(AD)

Who this might be right for
Dermatitis, Atopic
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. 246
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07678645
What this trial is testing

The Safety and Efficacy of Upadacitinib in Refractory Autoimmune Related Cholangitis and Atopic Dermatitis With Moderate to Severe Itching

Who this might be right for
Primary Biliary Cholangitis (PBC)Primary Sclerosing Cholangitis (PSC)Atopic Dermatitis (AD)
RenJi Hospital 44
Early research (Phase 1)Study completedNCT05405985
What this trial is testing

Study to Access the Relative Bioavailability of Subcutaneous Dose of Nemolizumab When Administered Via Auto-Injector Versus Dual-Chamber Syringe

Who this might be right for
Healthy Volunteers
Galderma R&D 192
Testing effectiveness (Phase 2)Ended earlyNCT04220411
What this trial is testing

AR100DP1 in Mild to Moderate Atopic Dermatitis (AD)

Who this might be right for
Dermatitis, Atopic
Arjil Pharmaceuticals LLC 17
Not applicableUnknownNCT03458624
What this trial is testing

Long-term Observational Study to Evalution the Safety and Efficacy of FURESTEM-AD Inj.

Who this might be right for
Atopic Dermatitis
Kang Stem Biotech Co., Ltd. 14
Testing effectiveness (Phase 2)Study completedNCT04313400
What this trial is testing

Topically Applied AMTX-100 CF for Adult Patients With Mild to Moderate Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Amytrx Therapeutics, Inc. 91
Post-approval studies (Phase 4)Study completedNCT00925730
What this trial is testing

Open-label Study to Investigate Systemic Exposure in Adult and Pediatric Atopic Dermatitis Patients Treated 8.5 Days With Pimecrolimus Cream 1% Under Occlusion

Who this might be right for
Atopic Dermatitis
Novartis 20
Large-scale testing (Phase 3)Study completedNCT02395133
What this trial is testing

Confirm the Efficacy and Safety of Different Dupilumab Dose Regimens in Adults With Atopic Dermatitis (AD)

Who this might be right for
Atopic Dermatitis
Regeneron Pharmaceuticals 422
Large-scale testing (Phase 3)Not Yet RecruitingNCT07377838
What this trial is testing

Study of ADSTEM Injection for Patients With Moderate to Severe Subacute and Chronic Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
EHL Bio Co., Ltd. 286
Not applicableLooking for participantsNCT05689151
What this trial is testing

Learn About Abrocitinib in Adult Patients With Moderate to Severe Atopic Dermatitis.

Who this might be right for
Atopic DermatitisEczema
Pfizer 183
Testing effectiveness (Phase 2)Study completedNCT05432596
What this trial is testing

Study of ATI-1777 in Patients 12 to 65 Years Old With Mild to Severe Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Aclaris Therapeutics, Inc. 250
Not applicableNot Yet RecruitingNCT04730024
What this trial is testing

Long-term Follow-up Study to Evaluate the Safety and Explore the Efficacy of Multiple Doses of FURESTEM-AD Inj

Who this might be right for
Atopic Dermatitis
Kang Stem Biotech Co., Ltd. 102
Next Page